Vice President (VP), Intellectual Property
Akebia TherapeuticsCambridge, Massachusetts, United States · Posted 1 month agoDescription
Akebia is seeking an experienced intellectual property lawyer to join its high performing team, head its intellectual property function and manage a multitude of complex intellectual property-related matters for the company. Reporting to the Chief Legal Officer, the successful candidate will be both a strategic business partner and positive cultural leader. This position will be based in Cambridge/Waltham, MA and work closely with the research and development (R&D) and chemistry manufacturing and controls (CMC) teams to identify new patent opportunities and develop and execute corresponding patent portfolio strategies. The Vice President, Intellectual Property will also counsel colleagues in matters related to patent portfolio and strategy, support due diligence efforts for evaluation of new in-licensing opportunities, and manage any intellectual property litigation matters.
Essential Functions and Duties- Responsible for the development and execution of the IP strategy and serve as the key advisor on intellectual property matters impacting the business
- Collaborate with Akebia’s R&D and CMC teams to prepare, file and prosecute patent applications
- Advise the Chief Legal Officer, Executive Leadership Team and Board of Directors regarding intellectual property matters
- Develop intellectual property strategies for Akebia’s product candidates
- Work closely with Akebia’s collaboration partners on patent matters
- Support business development efforts and lead IP due diligence work
- Negotiate, and assist in drafting intellectual property provisions in agreements and advise the business on related intellectual property risks
- Manage and direct outside counsel in intellectual property patent preparation and prosecution, litigation matters, and other intellectual property matters in a cost-effective manner
- Monitor the competitive patent landscape for potential risks and opportunities
The ideal candidate for the position of Vice President, Intellectual Property will have the following qualifications:
Basic Qualifications:
- J.D. and admission to the Patent Bar
- PhD in Organic Chemistry or Biology (or similar discipline)
- Small molecule and/or biologic patent experience
- Strong litigation experience
- At least 10 years of experience in law firm or in-house biopharmaceutical company settings
- Ability to build strong relationships across functions
- Excellent interpersonal, decision-making, organizational and communication skills
Preferred Qualifications:
- In-house experience with biopharmaceutical companies is a plus
- Strong organizational and project management skills with an ability to handle multiple tasks and quickly and effectively prioritize and make decisions
- Ability to think strategically and communicate complex concepts in ways that are understood and actionable by cross-functional teams
- Strong attention to detail and proactive approach
- Excellent verbal and written communication skills
- Confident, pragmatic, approachable and solution-oriented
- Comfortable in a fast-paced, deadline-driven environment
- Self-motivated and able to perform role independently, with a minimum level of supervision.
Base Compensation for this role will depend on a number of factors including a candidate’s qualifications, skills, competencies, and experience, and may fall outside of the range shown. Base pay is only one component of the company’s total rewards package, all regular employees are also eligible for the corporate bonus program or the incentive compensation program (if applicable), as well as equity. Additional benefits include health care, vision, dental, retirement, PTO, etc.
Similar jobs
Est. 277,517 USD
Nearly 37 million Americans are currently affected by Chronic Kidney Disease. 37 million. At Akebia we take that number very seriously and every day we come to work, with the purpose of bettering the lives of each person…
Est. 325,626 USD
Nearly 37 million Americans are currently affected by Chronic Kidney Disease. 37 million. At Akebia we take that number very seriously and every day we come to work, with the purpose of bettering the lives of each person…
Est. 286,934 USD
Nearly 37 million Americans are currently affected by Chronic Kidney Disease. 37 million. At Akebia we take that number very seriously and every day we come to work, with the purpose of bettering the lives of each person…
Est. 344,138 USD
Nearly 37 million Americans are currently affected by Chronic Kidney Disease. 37 million. At Akebia we take that number very seriously and every day we come to work, with the purpose of bettering the lives of each person…
Est. 195,230 USD
Nearly 37 million Americans are currently affected by Chronic Kidney Disease. 37 million. At Akebia we take that number very seriously and every day we come to work, with the purpose of bettering the lives of each person…
Est. 138,918 USD
Nearly 37 million Americans are currently affected by Chronic Kidney Disease. 37 million. At Akebia we take that number very seriously and every day we come to work, with the purpose of bettering the lives of each person…
Est. 199,683 USD
Nearly 37 million Americans are currently affected by Chronic Kidney Disease. 37 million. At Akebia we take that number very seriously and every day we come to work, with the purpose of bettering the lives of each person…
Est. 257,500 USD
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…
Est. 212,500 USD
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitmen…
Est. 327,500 USD
Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immu…
Est. 316,500 USD
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitmen…
Est. 352,500 USD
Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immu…
Est. 180,000 USD
Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immu…
Est. 167,500 USD
Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immu…
Est. 408,800 USD
At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team…
Est. 442,000 USD
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitmen…
Est. 172,500 USD
At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team…
Est. 177,000 USD
At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team…
Est. 320,000 USD
Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immu…
Est. 285,000 USD
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitmen…
Est. 232,500 USD
Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immu…
Est. 265,000 USD
Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immu…
Est. 302,220 USD
Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immu…
Est. 219,000 USD
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitmen…
Est. 140,000 USD
Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immu…
Est. 172,500 USD
At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team…
Est. 181,500 USD
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitmen…
Est. 375,000 USD
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitmen…
Est. 170,567 USD
Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immu…
Est. 290,000 USD
Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immu…